Clinicopathologic study of 8 cases of poorly differentiated cutaneous angiosarcoma of scalp.
- Author:
Si-Yuan CHEN
1
;
Chang-Zheng HUANG
;
Yue QIAN
;
Yan WU
;
Ya-Ting TU
Author Information
- Publication Type:Case Reports
- MeSH: Aged; Aged, 80 and over; Antigens, CD34; immunology; Biomarkers, Tumor; analysis; Cell Adhesion Molecules; Cell Differentiation; Endothelium; metabolism; Female; Hemangiosarcoma; immunology; Humans; Male; Middle Aged; Platelet Endothelial Cell Adhesion Molecule-1; immunology; Scalp; pathology; Skin Neoplasms; immunology; metabolism; pathology; Vimentin; analysis
- From: Chinese Journal of Pathology 2008;37(5):313-315
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the clinical and pathologic characteristics of poorly differentiated cutaneous angiosarcoma of scalp.
METHODSEight cases of poorly differentiated cutaneous angiosarcoma of scalp were enrolled into this study. The clinical manifestations and histopathologic features were analyzed. Immunohistochemical study for CD31, CD34, factor VIII-related antigen, vimentin, AE1/AE3, CAM5. 2, epithelial membrane antigen and carcinoembryonic antigen was performed.
RESULTSThe mean age of the patients was 69 years. The male-to-female ratio was 5 : 3. The tumor manifested clinically as bruise-like lesion in early phase, indurated erythematous plaque accompanied by nodules, ulcerations and bleeding in advanced phase. Histologically, the tumor was composed of solid sheets of undifferentiated spindle cells which were not easily recognizable as vascular in origin. Nuclear atypia was always present. The tumor cells in all of the 8 cases strongly expressed CD31, factor VIII-related antigen and vimentin. Weak expression of CD34, AE1/AE3 and CAMS. 2 was noted in 2, 4 and 4 cases, respectively. The staining for epithelial membrane antigen, carcinoembryonic antigen and S-100 was negative. Conclusions Angiosarcoma needs to be excluded by histologic examination whenever bruise-like and erythematous lesions occurring on scalp skin of elderly patients. The endothelial origin of the tumor cells can be confirmed with immunostaining for CD31, CD34 and factor VIII-related antigen.